Immunosuppressant	Monoclonal IgG	Selective adhesion molecule inhibitor
\|	\|	\|

Crizanlizumab (substance)
	Crizanlizumab

Id	830160007
Status	Primitive

Has disposition	Immunomodulator
Has disposition	Selective adhesion molecule inhibitor